Position in RYTM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$61,224,962
-$8,501,105 QoQ
Shares Held
703,978
+8.1% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 87.46722198705073.ToString("F0")%
Shared 0.ToString("F0")%
None 12.532778012949269.ToString("F0")%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. RYTM ranks #47 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in RYTM
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $61,224,962 | 703,978 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $69,726,067 | 651,402 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $46,979,533 | 465,190 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $33,141,888 | 524,480 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $26,699,473 | 504,049 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $31,353,666 | 560,087 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $24,340,601 | 464,604 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $19,530,226 | 475,651 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $7,923,753 | 182,870 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $10,649,224 | 231,656 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $10,004,650 | 436,408 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,701,449 | 103,181 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,864,516 | 216,621 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,096,102 | 243,685 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,639,826 | 230,197 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,787,597 | 430,747 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $2,943,264 | 255,492 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,678,258 | 268,363 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,683,383 | 205,466 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,744,543 | 446,606 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $2,145,057 | 100,849 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,492,622 | 50,206 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $339,762 | 15,679 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $547,486 | 24,551 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $168,941 | 11,100 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||